Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Acupressure for Cough in Lung Cancer Survivors

Official title: Acupressure for Cough in Lung Cancer Survivors: A Randomized Controlled Trial

Run by The University of Hong Kong · NCT07315672 · Data updated 2026-11-12

This trial tests whether self-administered acupressure can lessen cough and related symptoms in people who have survived lung cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations2 sites (Shenzhen, Guangdong and 1 other locations)
StatusRecruiting
StartedMarch 9, 2026
Main results expectedDecember 2026
Study endsFebruary 2027
Registry record updatedAugust 11, 2026
Trial IDNCT07315672 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with lung cancer (any stage/type) who have a cough rated 3 or higher and can perform self-acupressure.

Probably not a fit

Individuals who do not experience symptom relief or who have conditions preventing adherence to the protocol may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares an eight-week self-administered acupressure program to receiving an educational booklet for lung cancer survivors with cough. Participants will keep a diary of their acupressure practice and symptoms and be assessed at baseline, during early intervention, after the eight-week period, and eight weeks later. The study aims to see if acupressure can reduce cough and the related symptom cluster of dyspnea and fatigue, and improve overall symptom burden, daily functioning, and quality of life. Eligible participants are adults with a lung cancer diagnosis who have a cough of moderate or greater severity and can perform acupressure themselves, with literacy in Chinese and ability to communicate in Cantonese or Mandarin. The study is conducted at centers affiliated with The University of Hong Kong and its partners in Hong Kong and Shenzhen.

Why it matters

Potential benefit: If successful, participants may experience relief from cough and related symptoms and a better quality of life.

How similar studies have gone: Prior research in symptom management for cancer patients has shown benefits from non-pharmacologic approaches like acupressure in certain symptom clusters; this trial tests its applicability to lung cancer cough specifically.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* be at least 18 years of age;
* have a diagnosis of LC at any stage and of any pathological type;
* have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment;
* can perform acupressure independently in daily activities;
* be able to read Chinese and communicate in Cantonese or Mandarin;
* be able to provide informed consent.

Exclusion Criteria:

* have unstable chronic diseases other than LC;
* have received acupressure or acupuncture within the three months preceding study enrollment;
* have serious illnesses or other conditions that prevent the participants from following the intervention protocols;
* have a life expectancy of less than 3 months;
* Be currently participating in other research programs that may affect the outcomes under investigation.

Where it's running

  • University of Hong Kong-Shenzhen Hospital
    Shenzhen, Guangdong, China
    Recruiting
  • Queen Mary Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.